Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations.

Authors:
Hendy DA; Pena ES; Ontiveros-Padilla L; Dixon TA; Middleton DD and 9 more

Journal:
Bioeng Transl Med

Publication Year: 2023

DOI:
10.1002/btm2.10634

PMCID:
PMC10905549

PMID:
38435811

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Bioeng Transl Med

Abbreviation: Bioeng Transl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
4D-CT deformable image registration using unsupervised recursive cascaded full-resolution residual …
Xu L; Jiang P; Tsui T and 4 more (2023) - Transparency Score: 3/6
Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflamm…
Deng C; Liu Q; Zhao H and 9 more (2023) - Transparency Score: 3/6
Adipose-derived stem cells enriched with therapeutic mRNA TGF-β3 and IL-10 synergistically promote …
Wang W; Chen L; Zhang Y and 5 more (2023) - Transparency Score: 4/6
Adjustable extracellular matrix rigidity tumor model for studying stiffness dependent pancreatic du…
Zhang H; Chen J; Hu X and 2 more (2023) - Transparency Score: 3/6
A drug-selectable acoustic reporter gene system for human cell ultrasound imaging.
Howells AR; Welch PJ; Kim J and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s1: supplementary information."

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no conflicts to declare."

Evidence found in paper:

"FUNDING INFORMATION This work was supported, in part, by National Institutes of Health (NIH) NIAID Collaborative Influenza Vaccine Innovation Centers (CIVICs) Contract #75N93019C00052 (PI: Ross), NIH R01AI147497 (PI: Ainslie), and UNC Systems Genetics Core Facility Collaborative‐Cross Program Special Pilot 21‐0112 (PI: Ainslie). The UNC Flow Cytometry Core Facility (RRID:SCR_019170) is supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025